BridgeMD
New treatment option for Type 2 Diabetes
Official title JACARDI: A eHealth and Health Literacy Educational Training to Support Older Patients With Type II Diabetes
ClinicalTrials.gov ID: NCT06904690
What this study is testing
- What it's testing
- The JACARDI trial is a multicenter study involving an educational training, with the general objective to improve the eHealth of older adults in relation to the management of type 2 diabetes.
- Time commitment: about 10 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- Low eHealth literacy (eHeals scale ≤ 29)
- No acute or untreated medical problems
- Mini Mental State Examination (MMSE) ≥ 24
- Geriatric Depression Scale (GDS) \< 2
You likely can't join if
- A myocardial infarction or stroke within 6 months
- Painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility
- Uncontrolled hypertension
- Advanced Parkinson's disease or other neuromuscular disorder
- Metastatic cancer or immunosuppressive therapy
- Significant visual or hearing impairment
The study team makes the final eligibility decision.
Where it's taking place
- Ancona, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 10 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ancona, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.